Mon 08/14/2023 11:51 AM
Aenova’s sales reached €66.2 million in May, which was ahead of the €63.2 million budgeted and the €60.1 million the German pharma contract development and manufacturing organization, or CDMO, achieved the same month a year earlier. Adjusted EBITDA reached €11 million, exceeding both €8.3 million budgeted and the €7.5 million the group generated in the same period a year earlier. Reported EBITDA for May was €6 million.
Year-to-date sales climbed to €346.7 million from €318.7 million budgeted...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.